Patrick Hargutt
Fondatore presso Stanley Capital Partners LLP
Profilo
Patrick Hargutt founded Stanley Capital Partners LLP in 2020, where he is working as Founding Partner from 2020.
Mr. Hargutt also currently works at Stanley Lab, Inc., as Founding Director from 2021, Laboratoire X.O, as Board Director from 2022, and Noden Pharma DAC, as Director from 2020.
Mr. Hargutt also formerly worked at Healthcare AI Acquisition Corp., as Chief Financial Officer & Director and Monarch Alternative Capital (Private Equity), as Vice President from 2018 to 2019.
Mr. Hargutt received his undergraduate degree in 2010 from Technische Universität München.
Posizioni attive di Patrick Hargutt
Società | Posizione | Inizio |
---|---|---|
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Fondatore | 01/01/2020 |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Direttore/Membro del Consiglio | 01/09/2020 |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | 01/09/2022 |
Stanley Lab, Inc. | Direttore/Membro del Consiglio | 01/03/2021 |
Precedenti posizioni note di Patrick Hargutt
Società | Posizione | Fine |
---|---|---|
HEALTHCARE AI ACQUISITION CORP. | Direttore Finanziario/CFO | 12/06/2023 |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Investitore di Private Equity | 31/10/2019 |
Formazione di Patrick Hargutt
Technische Universität München | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
HEALTHCARE AI ACQUISITION CORP. | Finance |
Aziende private | 5 |
---|---|
Stanley Lab, Inc. | |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Health Technology |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Finance |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Health Technology |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Finance |
- Borsa valori
- Insiders
- Patrick Hargutt